Zacks.com featured highlights include Halozyme Therapeutics, Phibro, Leidos and PDD Holdings
Halozyme, Phibro, Leidos and PDD Holdings shine as GARP picks, blending discounted valuations with strong long-term growth potential.
Zacks·14h ago
More News
Bet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns
Broker upgrades boost Halozyme, Leidos and TransUnion, each projected for solid 2025 earnings growth and stronger returns.
Zacks·15h ago
4 PEG-Rated GARP Stocks That Offer Both Value and Growth
Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.
Zacks·2d ago
Are You Looking for a Top Momentum Pick? Why Halozyme Therapeutics (HALO) is a Great Choice
Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·3d ago
Best Momentum Stock to Buy for September 3rd
HALO, TROW and CARS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 3, 2025.
Zacks·3d ago
Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year?
Here is how Halozyme Therapeutics (HALO) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.
Zacks·3d ago
Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue?
Halozyme Therapeutics (HALO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·3d ago
How to Find Strong Buy Medical Stocks Using the Zacks Rank
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Zacks·3d ago
New Strong Buy Stocks for September 3rd
TDW, JRVR, HALO, SCSC and CSW have been added to the Zacks Rank #1 (Strong Buy) List on September 3, 2025.
Zacks·3d ago
Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.